Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
The COVID-19 battle dominates the news, but it doesn’t constitute all the news. Here’s what several Southern California Biotech Beach companies are doing that you might have missed.
Case Study | CMO/CDMO Automates Glycan Workflows to Increase Business Capacity
With the coronavirus pandemic pausing FTC reviews and complicating supply chains, Mylan is flying a holding pattern on its megamerger with Pfizer's Upjohn unit and scrambling to deal with ...
Leo Pharma is paying $40 million upfront and $530 million in biobucks to license a midstage experimental eczema and asthma drug.
In the race to detect and treat COVID-19, biotech, government and academia are joining forces to battle a disease that knows no borders.
OraSure, a profitable Bethlehem company best known for its home test that finds HIV in spit, has collected a $700,000 grant from the federal BARDA agency to get its COVID-19 test approved ...